168 related articles for article (PubMed ID: 34895720)
1. Long-term outcomes of living-donor lobar lung transplantation.
Sugimoto S; Date H; Miyoshi K; Otani S; Ishihara M; Yamane M; Toyooka S
J Thorac Cardiovasc Surg; 2022 Aug; 164(2):440-448. PubMed ID: 34895720
[TBL] [Abstract][Full Text] [Related]
2. Unilateral chronic lung allograft dysfunction is a characteristic of bilateral living-donor lobar lung transplantation.
Miyamoto E; Chen F; Aoyama A; Sato M; Yamada T; Date H
Eur J Cardiothorac Surg; 2015 Sep; 48(3):463-9. PubMed ID: 25468952
[TBL] [Abstract][Full Text] [Related]
3. Emphysematous changes and lower levels of plasma irisin are associated with bronchiolitis obliterans syndrome after bilateral living-donor lobar lung transplantation.
Shiotani T; Sugimoto S; Yamamoto H; Miyoshi K; Otani S; Suzawa K; Yamamoto H; Okazaki M; Yamane M; Toyooka S
Surg Today; 2022 Feb; 52(2):294-305. PubMed ID: 34251508
[TBL] [Abstract][Full Text] [Related]
4. Impact of chronic lung allograft dysfunction, especially restrictive allograft syndrome, on the survival after living-donor lobar lung transplantation compared with cadaveric lung transplantation in adults: a single-center experience.
Sugimoto S; Yamamoto H; Kurosaki T; Otani S; Okazaki M; Yamane M; Toyooka S; Oto T
Surg Today; 2019 Aug; 49(8):686-693. PubMed ID: 30790054
[TBL] [Abstract][Full Text] [Related]
5. Restrictive allograft dysfunction rather than bronchiolitis obliterans syndrome had a major impact on the overall survival after living-donor lobar lung transplantation.
Matsubara K; Otani S; Yamamoto H; Hashimoto K; Tanaka S; Shien K; Suzawa K; Miyoshi K; Yamamoto H; Okazaki M; Sugimoto S; Toyooka S
Surg Today; 2024 Apr; 54(4):317-324. PubMed ID: 37523071
[TBL] [Abstract][Full Text] [Related]
6. [Chronic Lung Allograft Dysfunction after Living-donor Lobar Lung Transplantation].
Sugimoto S; Tanaka S; Miyoshi K; Toyooka S
Kyobu Geka; 2022 Apr; 75(4):297-301. PubMed ID: 35342161
[TBL] [Abstract][Full Text] [Related]
7. Graft dysfunction immediately after reperfusion predicts short-term outcomes in living-donor lobar lung transplantation but not in cadaveric lung transplantation.
Mizota T; Miyao M; Yamada T; Sato M; Aoyama A; Chen F; Date H; Fukuda K
Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):314-20. PubMed ID: 26705301
[TBL] [Abstract][Full Text] [Related]
8. Living-donor lobar lung transplantation.
Date H
J Heart Lung Transplant; 2024 Jan; 43(1):162-168. PubMed ID: 37704161
[TBL] [Abstract][Full Text] [Related]
9. Redo living-donor lobar lung transplantation for bronchiolitis obliterans associated with antibody-mediated rejection.
Chen F; Miyagawa-Hayashino A; Yurugi K; Chibana N; Yamada T; Sato M; Aoyama A; Takakura S; Bando T; Date H
Transpl Int; 2014 Feb; 27(2):e8-12. PubMed ID: 24164400
[TBL] [Abstract][Full Text] [Related]
10. Intermediate outcomes of right-to-left inverted living-donor lobar lung transplantation.
Chen-Yoshikawa TF; Tanaka S; Yamada Y; Yutaka Y; Nakajima D; Ohsumi A; Hamaji M; Menju T; Date H
Eur J Cardiothorac Surg; 2019 Dec; 56(6):1046-1053. PubMed ID: 31722008
[TBL] [Abstract][Full Text] [Related]
11. Roles and practice of living-related lobar lung transplantation.
Nakajima D; Date H
J Thorac Dis; 2023 Sep; 15(9):5213-5220. PubMed ID: 37868887
[TBL] [Abstract][Full Text] [Related]
12. Living-donor lobar lung transplantation provides similar survival to cadaveric lung transplantation even for very ill patients†.
Date H; Sato M; Aoyama A; Yamada T; Mizota T; Kinoshita H; Handa T; Tanizawa K; Chin K; Minakata K; Chen F
Eur J Cardiothorac Surg; 2015 Jun; 47(6):967-72; discussion 972-3. PubMed ID: 25228745
[TBL] [Abstract][Full Text] [Related]
13. Acquired recipient pulmonary function is better than lost donor pulmonary function in living-donor lobar lung transplantation.
Kayawake H; Chen-Yoshikawa TF; Hamaji M; Nakajima D; Ohsumi A; Aoyama A; Date H
J Thorac Cardiovasc Surg; 2019 Dec; 158(6):1710-1716.e2. PubMed ID: 31399240
[TBL] [Abstract][Full Text] [Related]
14. Lung perfusion scintigraphy to detect chronic lung allograft dysfunction after living-donor lobar lung transplantation.
Yamamoto H; Sugimoto S; Kurosaki T; Miyoshi K; Otani S; Okazaki M; Yamane M; Oto T; Toyooka S
Sci Rep; 2020 Jun; 10(1):10595. PubMed ID: 32601414
[TBL] [Abstract][Full Text] [Related]
15. Outcome and growth of lobar graft after pediatric living-donor lobar lung transplantation.
Tanaka S; Nakajima D; Sakamoto R; Oguma T; Kawaguchi A; Ohsumi A; Ohata K; Ueda S; Yamagishi H; Kayawake H; Yutaka Y; Yamada Y; Hamaji M; Hamada S; Tanizawa K; Handa T; Suga T; Baba S; Hiramatsu H; Ikeda T; Date H
J Heart Lung Transplant; 2023 May; 42(5):660-668. PubMed ID: 36585287
[TBL] [Abstract][Full Text] [Related]
16. Native lung complications after living-donor lobar lung transplantation.
Mineura K; Chen-Yoshikawa TF; Tanaka S; Yamada Y; Yutaka Y; Nakajima D; Ohsumi A; Hamaji M; Menju T; Date H
J Heart Lung Transplant; 2021 May; 40(5):343-350. PubMed ID: 33602629
[TBL] [Abstract][Full Text] [Related]
17. Long-term improvement in pulmonary function after living donor lobar lung transplantation.
Yamane M; Date H; Okazaki M; Toyooka S; Aoe M; Sano Y
J Heart Lung Transplant; 2007 Jul; 26(7):687-92. PubMed ID: 17613398
[TBL] [Abstract][Full Text] [Related]
18. Comparison of living-donor lobar lung transplantation and cadaveric lung transplantation for pulmonary hypertension.
Kayawake H; Tanaka S; Yamada Y; Baba S; Kinoshita H; Yamazaki K; Ikeda T; Minatoya K; Yutaka Y; Hamaji M; Ohsumi A; Nakajima D; Date H
Eur J Cardiothorac Surg; 2023 Apr; 63(4):. PubMed ID: 36723127
[TBL] [Abstract][Full Text] [Related]
19. Comparison of de novo donor-specific antibodies between living and cadaveric lung transplantation.
Gochi F; Chen-Yoshikawa TF; Kayawake H; Ohsumi A; Tanaka S; Yamada Y; Yutaka Y; Nakajima D; Hamaji M; Yurugi K; Hishida R; Date H
J Heart Lung Transplant; 2021 Jul; 40(7):607-613. PubMed ID: 34078558
[TBL] [Abstract][Full Text] [Related]
20. Twenty-year Follow-up of the First Bilateral Living-donor Lobar Lung Transplantation in Japan.
Komatsu M; Yamamoto H; Shomura T; Sonehara K; Ichiyama T; Urushihata K; Ushiki A; Yasuo M; Wakamatsu T; Sugimoto S; Oto T; Date H; Koizumi T; Hanaoka M; Kubo K
Intern Med; 2019 Nov; 58(21):3133-3137. PubMed ID: 31292405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
